Amdocs Limited (NASDAQ:DOX) Shares Sold by Todd Asset Management LLC

Todd Asset Management LLC reduced its position in Amdocs Limited (NASDAQ:DOXFree Report) by 14.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 350,404 shares of the technology company’s stock after selling 59,866 shares during the period. Todd Asset Management LLC owned approximately 0.30% of Amdocs worth $30,797,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of DOX. GAMMA Investing LLC purchased a new stake in shares of Amdocs in the fourth quarter worth about $25,000. Oakworth Capital Inc. acquired a new stake in Amdocs in the fourth quarter valued at approximately $26,000. Operose Advisors LLC raised its stake in shares of Amdocs by 148.0% during the third quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after purchasing an additional 185 shares during the period. VisionPoint Advisory Group LLC lifted its position in shares of Amdocs by 77.7% during the third quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company’s stock worth $42,000 after purchasing an additional 220 shares in the last quarter. Finally, Allworth Financial LP boosted its stake in shares of Amdocs by 16,840.0% in the third quarter. Allworth Financial LP now owns 847 shares of the technology company’s stock valued at $72,000 after purchasing an additional 842 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

DOX traded up $0.26 during trading hours on Friday, hitting $83.90. 660,338 shares of the stock were exchanged, compared to its average volume of 592,389. The stock has a market cap of $9.86 billion, a price-to-earnings ratio of 17.97, a price-to-earnings-growth ratio of 1.36 and a beta of 0.70. The stock has a 50-day simple moving average of $88.95 and a 200-day simple moving average of $87.43. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29. Amdocs Limited has a 12 month low of $78.38 and a 12 month high of $99.75.

Amdocs (NASDAQ:DOXGet Free Report) last released its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.16. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. Amdocs’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.33 earnings per share. Analysts anticipate that Amdocs Limited will post 5.87 earnings per share for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Friday, March 29th were paid a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date was Wednesday, March 27th. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s dividend payout ratio (DPR) is currently 41.11%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on DOX shares. Citigroup boosted their price objective on shares of Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Barclays increased their price target on Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Finally, StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $108.60.

Check Out Our Latest Analysis on Amdocs

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.